Kehoe, PG
21  Ergebnisse:
Personensuche X
?
1

Dementia risk reduction: why haven't the pharmacological ri..:

Peters, R ; Breitner, J ; James, S...
https://openaccess.sgul.ac.uk/id/eprint/113353/6/A%20D%20Transl%20Res%20Clin%20Interv%20-%202021%20-%20Peters%20-%20Dementia%20risk%20reduction%20why%20haven%20t%20the%20pharmacological%20risk%20reduction.pdf.  , 2021
 
?
2

Dementia risk reduction: why haven't the pharmacological ri..:

Peters, R ; Breitner, J ; James, S...
https://discovery.ucl.ac.uk/id/eprint/10141591/1/Dementia%20risk%20reduction_TRC2-7-e12202.pdf.  , 2021
 
?
3

Losartan to slow the progression of mild-to-moderate Alzhei..:

Kehoe, PG ; Turner, N ; Howden, B...
https://discovery.ucl.ac.uk/id/eprint/10138486/1/Barnes_Losartan%20to%20slow%20the%20progression%20of%20mild-to-moderate%20Alzheimer%E2%80%99s%20disease%20through%20angiotensin%20targeting_VoR.pdf.  , 2021
 
?
4

Safety and efficacy of losartan for the reduction of brain ..:

Kehoe, PG ; Turner, N ; Howden, B...
https://discovery.ucl.ac.uk/id/eprint/10137030/1/Barnes-1-s2.0-S1474442221002635-main.pdf.  , 2021
 
?
5

Baseline Results: The Association between Cardiovascular Ri..:

Kumar, VV ; Huang, H ; Zhao, L...
https://discovery.ucl.ac.uk/id/eprint/10095706/3/Zetterberg_Kumar.pdf.  , 2020
 
?
6

Cerebrospinal Fluid Changes in the Renin-Angiotensin System..:

Kehoe, PG ; Al Mulhim, N ; Zetterberg, H..
https://discovery.ucl.ac.uk/id/eprint/10084060/3/Zetterberg_Miners.pdf.  , 2019
 
?
7

The Epistasis Project: A Multi-Cohort Study of the Effects ..:

Belbin, O ; Morgan, K ; Medway, C...
https://discovery.ucl.ac.uk/id/eprint/10073907/1/Cortina%20Borja_13913_a1514_Brookes.pdf.  , 2019
 
?
8

Polygenic risk and hazard scores for Alzheimer's disease pr..:

Leonenko, G ; Sims, R ; Shoai, M...
https://discovery.ucl.ac.uk/id/eprint/10071617/1/Leonenko_et_al-2019-Annals_of_Clinical_and_Translational_Neurology.pdf.  , 2019
 
?
9

CSF evidence of pericyte damage in Alzheimer's disease is a..:

Miners, JS ; Kehoe, PG ; Love, S..
https://discovery.ucl.ac.uk/id/eprint/10082645/7/Zetterberg_CSF%20evidence%20of%20pericyte%20damage%20in%20Alzheimer%27s%20disease%20is%20associated%20with%20markers%20of%20blood-brain%20barrier%20dysfunction%20and%20disease%20pathology_VoR.pdf.  , 2019
 
?
10

Progress towards standardised diagnosis of vascular cogniti..:

Kehoe, P ; Skrobot, OA ; Black, SE...
https://www.repository.cam.ac.uk/handle/1810/271610.  , 2018
 
?
11

Small vessels, dementia and chronic diseases – molecular me..:

Horsburgh, K ; Wardlaw, JM ; van Agtmael, T...
https://discovery.ucl.ac.uk/id/eprint/10052456/1/Small%20vessels,%20dementia%20and%20chronic%20diseases.pdf.  , 2018
 
?
12

Progress toward standardized diagnosis of vascular cognitiv..:

Skrobot, OA ; Black, SE ; Chen, C...
https://discovery.ucl.ac.uk/id/eprint/10057880/3/Werring_VICCCS-2%20PGKehoe%20Revised%20MS%20CLEAN.pdf.  , 2018
 
?
13

The Rationale and Design of the Reducing Pathology in Alzhe..:

Kehoe, PG ; Blair, PS ; Howden, B...
https://discovery.ucl.ac.uk/id/eprint/10042285/1/Revised%20%28CLEAN%29%20RADAR%20Protocol%20Paper%20SUBMITTED%2025_09_2017.pdf.  , 2017
 
?
14

The Vascular Impairment of Cognition Classification Consens..:

Skrobot, OA ; Love, S ; Kehoe, PG...
https://discovery.ucl.ac.uk/id/eprint/1560336/3/Werring_VICCCS%20concept%20paper%20draft%20final%20to%20participants.pdf.  , 2017
 
?
15

Discovery by the Epistasis Project of an epistatic interact..:

Bullock, JM ; Medway, C ; Cortina-Borja, M...
Bullock , JM , Medway , C , Cortina-Borja , M , Turton , JC , Prince , JA , Verbaas , C , Schuur , M , Breteler , M , Duijn , C , Kehoe , PG , Barber , R , Coto , E , Alvarez , V , Deloukas , P , Hammond , N , Combarros , O , Mateo , I , Warden , DR , Lehmann , MG , Belbin , O , Brown , K , Wilcock , GK , Heun , R , Kolsch , H , Smith , AD , Lehmann , DJ & Morgan , K 2013 , ' Discovery by the Epistasis Project of an epistatic interaction between the GSTM3 gene and the HHEX/IDE/KIF11 locus in the risk of Alzheimer's disease ' , Neurobiology of Aging , vol. 34 , no. 4 . https://doi.org/10.1016/j.neurobiolaging.2012.08.010.  , 2013
 
1-15